Does CAPMATINIB Cause Oedema? 130 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Oedema have been filed in association with CAPMATINIB (TABRECTA). This represents 5.7% of all adverse event reports for CAPMATINIB.
130
Reports of Oedema with CAPMATINIB
5.7%
of all CAPMATINIB reports
12
Deaths
17
Hospitalizations
How Dangerous Is Oedema From CAPMATINIB?
Of the 130 reports, 12 (9.2%) resulted in death, 17 (13.1%) required hospitalization, and 3 (2.3%) were considered life-threatening.
Is Oedema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPMATINIB. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does CAPMATINIB Cause?
Death (411)
Peripheral swelling (283)
Fatigue (257)
Oedema peripheral (247)
Nausea (240)
Malignant neoplasm progression (178)
Dyspnoea (141)
Asthenia (113)
Non-small cell lung cancer (96)
Decreased appetite (95)
What Other Drugs Cause Oedema?
RITUXIMAB (2,791)
PREDNISONE (2,721)
AMBRISENTAN (2,651)
METHOTREXATE (2,244)
ADALIMUMAB (2,141)
TOCILIZUMAB (1,836)
FOLIC ACID (1,781)
ABATACEPT (1,754)
TREPROSTINIL (1,705)
DICLOFENAC (1,691)
Which CAPMATINIB Alternatives Have Lower Oedema Risk?
CAPMATINIB vs CAPREOMYCIN
CAPMATINIB vs CAPSAICIN
CAPMATINIB vs CAPTOPRIL
CAPMATINIB vs CARBAMAZEPINE
CAPMATINIB vs CARBETOCIN